BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2002
View Archived Issues
Serono offers brief R&D overview at investor conference
Read More
Cytomyx and Papworth Hospital enter cardiovascular collaboration
Read More
Amgen updates investors at healthcare conference
Read More
Aventis discusses strategy for long-term growth in San Francisco
Read More
Travatan introduced in the U.K.
Read More
Industry leader Pfizer expects growth driven by broad and deep pipeline
Read More
Lilly anticipates launch of four NCEs during 2002
Read More
Plant extract proves highly effective against melanoma in animals
Read More
Topoisomerase inhibitor ER-37328 exerts potent antitumor activity in vitro and in vivo
Read More
VaxGen AIDS vaccine induces broad immune response to HIV subtypes
Read More
Initiation of phase III trial of Ceplene/IL-2 in metastatic melanoma with liver metastases
Read More
Dosing in phase IIA trial of AN-1792 in Alzheimer's disease temporarily suspended
Read More
Zimmer and Isto collaborate on Neocartilage allograft tissue development and commercialization
Read More
Geographical differences observed in Cidecin comparative phase III trial
Read More
CancerVax completes Cell Matrix acquisition
Read More
Hydroxyfasudil, a Rho kinase inhibitor with antianginal effects
Read More
INGAP in first clinical trial to test islet neogenesis in diabetes patients
Read More
Biovitrum describes 11beta-HSD1 inhibitors
Read More
More convenient formulation of MS medication cleared by FDA
Read More
Merck identifies benzodiazepine derivatives that inhibit Abeta formation
Read More
Macrolides for use as immunosuppressants in inflammatory conditions described in Novartis patent
Read More
Nippon Shinyaku scientists design tropolone derivatives that inhibit 12-lipoxygenase
Read More
3-Phenylpropionic acid derivatives synthesized by Kyorin useful in arteriosclerosis Rx
Read More
Ligands for GABA-A receptors designed by Merck team
Read More